Hailey-Hailey disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2841OMIM:169600Q82.8
Who is this for?
Show terms as
1Active trials19Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hailey-Hailey disease, also known as familial benign chronic pemphigus or benign familial pemphigus, is a rare genetic skin disorder caused by mutations in the ATP2C1 gene, which encodes a calcium pump essential for proper cell-to-cell adhesion in the epidermis. The defective calcium signaling leads to impaired formation of desmosomes, the structures that hold skin cells (keratinocytes) together, resulting in acantholysis — the loss of cohesion between skin cells. The disease primarily affects the skin, with recurrent episodes of blistering, erosions, and maceration occurring predominantly in intertriginous areas (skin folds) such as the groin, axillae (armpits), neck, and under the breasts. Lesions often present as painful, erythematous, crusted, and sometimes malodorous plaques that can significantly impair quality of life. Flare-ups are commonly triggered by friction, heat, sweating, secondary bacterial or fungal infections, and ultraviolet light exposure. Symptoms typically first appear in the second to fourth decade of life, though onset can vary. Longitudinal white bands on the fingernails (longitudinal leukonychia) may also be observed. There is currently no cure for Hailey-Hailey disease. Treatment is primarily aimed at managing symptoms and preventing flares. First-line approaches include topical corticosteroids, topical antibiotics, and antifungal agents to control secondary infections. For more severe or refractory cases, systemic treatments such as oral antibiotics, dapsone, or retinoids may be used. Procedural interventions including carbon dioxide laser ablation, botulinum toxin injections (to reduce sweating), photodynamic therapy, and surgical excision of affected areas have shown benefit in selected patients. General measures such as wearing loose-fitting clothing, minimizing friction, and keeping skin folds dry are important adjunctive strategies.

Also known as:

Clinical phenotype terms— hover any for plain English:

AcantholysisHP:0100792Skin vesicleHP:0200037
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Mar 2025Efficacy of Guselkumab in Treating Hailey Hailey Disease

Yale University — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Hailey-Hailey disease.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Phase 21 trial
Efficacy of Guselkumab in Treating Hailey Hailey Disease
Phase 2
Actively Recruiting
PI: Keith Choate, MD, PhD (Yale University) · Sites: New Haven, Connecticut · Age: 1890 yrs

Specialists

19 foundView all specialists →
ES
Elena Sukhanova
Specialist
1 Hailey-Hailey disease publication
AB
Abhinav Bansal
CHICAGO, IL
Specialist
1 Hailey-Hailey disease publication
KS
Kabir Sardana
Specialist
1 Hailey-Hailey disease publication
XX
Xiao Xue
Specialist
1 Hailey-Hailey disease publication
BR
Bertrand Richert
Specialist
1 Hailey-Hailey disease publication
OM
Olivia Mathot
Specialist
1 Hailey-Hailey disease publication
NG
Nefeli Giannopoulou
Specialist
1 Hailey-Hailey disease publication
AM
Aishwarya Muddebihal
Specialist
1 Hailey-Hailey disease publication
DM
Denise Miyamoto
Specialist
1 Hailey-Hailey disease publication
CS
Claudia Giuli Santi
Specialist
1 Hailey-Hailey disease publication
NA
Nikolai Arsentev
Specialist
1 Hailey-Hailey disease publication
CS
Camila Arai Seque
Specialist
1 Hailey-Hailey disease publication
ME
Milvia Maria Simões E Silva Enokihara
Specialist
1 Hailey-Hailey disease publication
DN
Diego Vanderlei Medeiros da Nóbrega
Specialist
1 Hailey-Hailey disease publication
AP
Adriana Maria Porro
Specialist
1 Hailey-Hailey disease publication
SL
Sang Eun Lee
Specialist
PI on 1 active trial
VV
Valerie Verstraeten
Specialist
PI on 1 active trial
KC
Keith Choate
NEW HAVEN, CT
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hailey-Hailey disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hailey-Hailey diseaseForum →

No community posts yet. Be the first to share your experience with Hailey-Hailey disease.

Start the conversation →

Latest news about Hailey-Hailey disease

Disease timeline:

New recruiting trial: Efficacy of Guselkumab in Treating Hailey Hailey Disease

A new clinical trial is recruiting patients for Hailey-Hailey disease

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hailey-Hailey disease

What is Hailey-Hailey disease?

Hailey-Hailey disease, also known as familial benign chronic pemphigus or benign familial pemphigus, is a rare genetic skin disorder caused by mutations in the ATP2C1 gene, which encodes a calcium pump essential for proper cell-to-cell adhesion in the epidermis. The defective calcium signaling leads to impaired formation of desmosomes, the structures that hold skin cells (keratinocytes) together, resulting in acantholysis — the loss of cohesion between skin cells. The disease primarily affects the skin, with recurrent episodes of blistering, erosions, and maceration occurring predominantly in

How is Hailey-Hailey disease inherited?

Hailey-Hailey disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hailey-Hailey disease typically begin?

Typical onset of Hailey-Hailey disease is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Hailey-Hailey disease?

Yes — 1 recruiting clinical trial is currently listed for Hailey-Hailey disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Hailey-Hailey disease?

19 specialists and care centers treating Hailey-Hailey disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.